Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy
S. J. Luen, R. Salgado, M. V. Dieci, A. Vingiani, G. Curigliano, R. E. Gould, C. Castaneda, T. D'Alfonso, J. Sanchez, E. Cheng, E. Andreopoulou, M. Castillo, S. Adams, S. Demaria, W. F. Symmans, S. Michiels, S. Loi
Profundice en los temas de investigación de 'Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy'. En conjunto forman una huella única.